ArticleEClinicalMedicine2026

Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials.

Bing-Yan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.